ANBT
VRTX icon

American National Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

American National Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98K Buy
+6
New +$2.66K ﹤0.01% 576
2026
Q1 		– Sell
-76
Closed -$34.5K – 714
2025
Q4 		$34.5K Hold
76
– – ﹤0.01% 403
2025
Q3 		$29.8K Sell
76
-4
-5% -$1.67K ﹤0.01% 420
2025
Q2 		$35.6K Buy
80
+67
+515% +$30.9K ﹤0.01% 415
2025
Q1 		$6.3K Buy
13
+2
+18% +$932 ﹤0.01% 494
2024
Q4 		$4.43K Hold
11
– – ﹤0.01% 466
2024
Q3 		$5.12K Hold
11
– – ﹤0.01% 433
2024
Q2 		$5.16K Hold
11
– – ﹤0.01% 494
2024
Q1 		$4.6K Sell
11
-63
-85% -$26.6K ﹤0.01% 444
2023
Q4 		$30.1K Sell
74
-24
-24% -$8.87K ﹤0.01% 330
2023
Q3 		$34.1K Buy
98
+3
+3% +$1.05K 0.01% 313
2023
Q2 		$33.4K Sell
95
-6
-6% -$2.02K 0.01% 316
2023
Q1 		$31.8K Sell
101
-10
-9% -$3K 0.01% 316
2022
Q4 		$32K Buy
111
+54
+95% +$16.5K 0.01% 298
2022
Q3 		$17K Buy
57
+8
+16% +$2.3K ﹤0.01% 327
2022
Q2 		$14K Hold
49
– – ﹤0.01% 276
2022
Q1 		$13K Buy
49
+38
+345% +$9.02K ﹤0.01% 291
2021
Q4 		$2K Hold
11
– – ﹤0.01% 329
2021
Q3 		$2K Hold
11
– – ﹤0.01% 279
2021
Q2 		$2K Hold
11
– – ﹤0.01% 275
2021
Q1 		$2K Buy
+11
New +$2.42K ﹤0.01% 260
2017
Q1 		– Sell
-9
Closed -$1K – 325
2016
Q4 		$1K Buy
+9
New +$732 ﹤0.01% 278

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

American National Bank & Trust's VRTX Position: Q2 2026 in Review

American National Bank & Trust opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 6 shares worth $2.98K. The stake represents ﹤0.01% of the portfolio and ranks #576 among its holdings. This is a return to the name: American National Bank & Trust previously reported a position in VRTX as recently as Q4 2025.

American National Bank & Trust first reported a position in VRTX in Q4 2016 and has held it in 22 quarters since. The position peaked at $35.6K in Q2 2025. 610 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • American National Bank & Trust held 6 shares of Vertex Pharmaceuticals worth $2.98K as of Q2 2026.
  • Vertex Pharmaceuticals was a new American National Bank & Trust position in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of American National Bank & Trust's portfolio in Q2 2026, its #576 holding.
  • American National Bank & Trust first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 22 quarters since.
  • American National Bank & Trust's Vertex Pharmaceuticals position peaked at $35.6K in Q2 2025.
  • 610 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.